HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW (JAN 2010)

The OPPI: A Soldier of Indian Pharma Marketing and Research

Jeetu Gangil, Sanghmitra Gautam, Dr Kishore, Girish Thunga

Introduction: The Organization of Pharmaceutical Producers of India (OPPI) established in 1965. It is a leading organization of pharmaceutical manufactures in India. Mission of this organization is to serve the collective interests of the members professionally so as to make sure a healthy environment for commercial growth of pharmaceutical market. Its membership consists of companies with international collaboration and many Indian pharmaceutical companies. It represents mostly research based companies in India. It organizes national and international seminars and workshops relating to key issues of the pharmaceutical business and healthcare. It supports scientific research by professional and academic institutes. All OPPI members adhere to the Code of Pharmaceutical Marketing Practices of International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). OPPI has developed the code for its members on the basis of IFPMA Code of Pharmaceutical Marketing Practices. OPPI is an active member of IFPMA, Geneva, and the World Self-Medication Industry (WSMI) France. OPPI is actively engaged in designing and conducting training programmes for managers working in the Pharmaceutical Industry to furnish them for competing in the global setting. OPPI identifies itself with the country’s national objectives in health and encourages its members to make significant contributions to social concerns and actively promotes Corporate Social Responsibility (CSR).

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a non-profit, non-governmental Organization (NGO) representing national industry associations and company of developing countries. Member of the IFPMA are research-based pharmaceutical, biotech and vaccine companies. In the research and development pipeline, the pharmaceutical industry is working on more than 700 new medicines and vaccines for infectious diseases including HIV, AIDS, cancer, heart disease and stroke and The main objectives of IFPMA is to encourage a worldwide policy environment that is encouraging to innovation in medicine, both therapeutic and preventative for the benefit of patients around the world.

 

For full text of this article contact the publisher on info@kppub.com

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.